Imagenetix Inc Asset Turnover Ratio (IAGX), as of first quarter 2015, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Imagenetix Inc  (IAGX)
 

Imagenetix Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Imagenetix Inc's asset turnover ratio, the ratio that measures the ability of Imagenetix Inc's assets to generate revenue, sequentially decreased to 0.14 in the first quarter (Jun 30 2015), which does not come as a surprise, as the Imagenetix Inc continue to experience difficult business climate.

Within sector 109 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the First Quarter 2015 compared to the preceding quarter from 0 to 3298.

Asset Turnover Ratio Definition



IAGX Asset Turnover Ratio (Jun 30 2015)
I. Quarter
(Dec 31 2014)
III. Quarter
(Sep 30 2014)
II. Quarter
(Dec 31 2011)
III. Quarter
(Sep 30 2011)
II. Quarter
Y / Y Asset Change 376.3 % 468.33 % 83.28 % 89.67 % -
Y / Y Revenue Change -56.93 % -51.63 % -90.31 % -87.46 % -19.2 %
Asset Turnover Ratio (TTM) 0.14 0.24 0.38 0.83 1.98
IAGX's Total Ranking # 3298 # 0 # 0 # #
Seq. Asset Change -0.52 % 3.39 % -0.17 % 363.89 % 18.7 %
Seq. Revenue Change 43.17 % 60.48 % -59.3 % -53.94 % 60.81 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 110
Healthcare Sector # 331
Overall Market # 3298

Asset Turnover Ratio Statistics
High Average Low
0.17 0.17 0.17
(Jun 30 2015)  







Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2015, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2015 Assets at quarter ending Jun 30 2015
Genmark Diagnostics Inc   0.37 $ 33.879  Millions$ 91.414  Millions
Cytokinetics Incorporated  0.37 $ 42.129  Millions$ 113.768  Millions
Harrow Inc   0.37 $ 4.521  Millions$ 12.220  Millions
Achaogen, Inc.  0.36 $ 25.700  Millions$ 70.743  Millions
Eagle Pharmaceuticals inc   0.36 $ 50.722  Millions$ 140.127  Millions
Alerislife Inc   0.36 $ 2,371.448  Millions$ 6,570.710  Millions
Aethlon Medical Inc   0.36 $ 0.904  Millions$ 2.535  Millions
Clearpoint Neuro Inc   0.36 $ 3.429  Millions$ 9.624  Millions
Dyax Corp  0.36 $ 94.812  Millions$ 267.014  Millions
Avid Bioservices Inc   0.35 $ 30.956  Millions$ 87.514  Millions
Endonovo Therapeutics Inc   0.35 $ 0.021  Millions$ 0.059  Millions
Durect Corp  0.35 $ 17.741  Millions$ 50.395  Millions
Xenon Pharmaceuticals Inc   0.35 $ 26.127  Millions$ 74.373  Millions
Trivascular Technologies, Inc.  0.35 $ 34.724  Millions$ 98.998  Millions
Vyant Bio Inc   0.35 $ 15.813  Millions$ 45.440  Millions
Geovax Labs Inc   0.34 $ 0.720  Millions$ 2.102  Millions
Ionis Pharmaceuticals Inc   0.34 $ 311.935  Millions$ 920.326  Millions
Ani Pharmaceuticals Inc  0.34 $ 76.739  Millions$ 226.863  Millions
Alkermes Plc   0.34 $ 638.147  Millions$ 1,899.644  Millions
Amarin Corp Plcuk  0.34 $ 64.269  Millions$ 191.746  Millions
Hologic Inc  0.33 $ 2,662.800  Millions$ 8,163.775  Millions
Cerus Corporation  0.32 $ 36.471  Millions$ 113.950  Millions
Biorestorative Therapies Inc   0.32 $ 0.573  Millions$ 1.804  Millions
Ardelyx inc   0.31 $ 37.962  Millions$ 121.182  Millions
Vycor Medical Inc   0.31 $ 1.208  Millions$ 3.858  Millions
Vivus Inc  0.31 $ 110.760  Millions$ 356.203  Millions
Atossa Therapeutics Inc   0.31 $ 4.574  Millions$ 14.725  Millions
Cytosorbents Corporation  0.31 $ 3.723  Millions$ 12.015  Millions
Prestige Consumer Healthcare Inc   0.31 $ 761.053  Millions$ 2,456.810  Millions
Fresh Tracks Therapeutics Inc   0.31 $ 17.385  Millions$ 56.503  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.